Elevated plasma MCP-1 concentration following traumatic brain injury as a potential predisposition factor associated with an increased risk for subsequent development of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 31, Issue 2, 2012, Pages 301-313

  Ho, Lap ^a   Dams O'Connor, Kristen ^a   Tang, Cheuk Y ^a   Gordon, Wayne ^a   Peskind, Elaine R ^c   Yemul, Shrishailam ^a   Haroutunian, Vahram ^a   Pasinetti, Giulio Maria ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; biomarker; long term clinical TBI phenotypes; mild cognitive impairment; monocyte chemotactic protein 1; plasma; traumatic brain injury

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ALZHEIMER DISEASE; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NERVE FIBER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; TRAUMATIC BRAIN INJURY;

EID: 84865578428     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120598     Document Type: Article

References (72)

1. Centers for Disease Control and Prevention (1999) Traumatic brain injury in the United States: A report to congress, http://www.cdc.gov/ncipc/pub-res/tbi congress/TBI in the US.PDF.
2. McDowell S, Whyte J, D'Esposito M (1997) Working memory impairments in traumatic brain injury: Evidence from a dual-task paradigm. Neuropsychologia 35, 1341-1353. (Pubitemid 27455561)
3. Schretlen DJ, Shapiro AM (2003) A quantitative review of the effects of traumatic brain injury on cognitive functioning. Int Rev Psychiatry 15, 341-349. (Pubitemid 37421586)
4. Huisman TA, Schwamm LH, Schaefer PW, Koroshetz WJ, Shetty-Alva N, Ozsunar Y, Wu O, Sorensen AG (2004) Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. AJNR Am J Neuroradiol 25, 370-376. (Pubitemid 38374913)
5. Kou Z, Wu Z, Tong KA, Holshouser B, Benson RR, Hu J, Haacke EM (2010) The role of advanced MR imaging findings as biomarkers of traumatic brain injury. J Head Trauma Rehabil 25, 267-282.
6. Scheid R, Walther K, Guthke T, Preul C, von Cramon DY (2006) Cognitive sequelae of diffuse axonal injury. Arch Neurol 63, 418-424.
7. Elder GA, Cristian A (2009) Blast-related mild traumatic brain injury: Mechanisms of injury and impact on clinical care. Mt Sinai J Med 76, 111-118.
8. Vasterling JJ, Proctor SP, Amoroso P, Kane R, Heeren T, White RF (2006) Neuropsychological outcomes of army personnel following deployment to the Iraq war. JAMA 296, 519-529. (Pubitemid 44157126)
9. Hannay HJ, Howieson DB, Loring DW, Fischer JS, Lezak MD (2004) Neuropathology for neuropsychologists. In Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. Oxford [Oxfordshire]: Oxford University Press. pp. 160.
10. van Duijn CM, Tanja TA, Haaxma R, Schulte W, Saan RJ, Lameris AJ, ntonides-Hendriks G, Hofman A (1992) Head trauma and the risk of Alzheimer's disease. Am J Epidemiol 135, 775-782.
11. Committee on Gulf War and Health Outcomes (2008) Gulf war and health: Volume 7: Long-term consequences of traumatic brain injury, The National Academic Press, Washington, DC.
12. Ruan L, Kang Z, Pei G, Le Y (2009) Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Curr Alzheimer Res 6, 531-540.
13. Iverson GL, Lange RT, Gaetz M, Zasler ND (2007) Mild TBI. In Brain Injury Medicine: Principles and Practice, Zasler N, Katz D, Zafonte R, Eds. Demos Medical Publishing, New York, pp. 333-371.
14. Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, MarionDW,Wisniewski SR, DeKosky ST (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190, 192-203. (Pubitemid 39335718)
15. Marklund N, Blennow K, Zetterberg H, Ronne-Engstrom E, Enblad P, Hillered L (2009) Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J Neurosurg 110, 1227-1237.
16. Olsson A, Csajbok L, Ost M, Hoglund K, Nylen K, Rosengren L, Nellgard B, Blennow K (2004) Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J Neurol 251, 870-876. (Pubitemid 39005974)
17. Szczygielski J, Mautes A, Steudel WI, Falkai P, Bayer TA, Wirths O (2005) Traumatic brain injury: Cause or risk of Alzheimer's disease? A review of experimental studies. J Neural Transm 112, 1547-1564. (Pubitemid 41504269)
18. Liliang PC, Liang CL, Weng HC, Lu K, Wang KW, Chen HJ, Chuang JH (2010) Tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 160, 302-307.
19. Gao X, Deng P, Xu ZC, Chen J (2011) Moderate traumatic brain injury causes acute dendritic and synaptic degeneration in the hippocampal dentate gyrus. PLoS One 6, e24566.
20. Gobbel GT, Bonfield C, Carson-Walter EB, Adelson PD (2007) Diffuse alterations in synaptic protein expression following focal traumatic brain injury in the immature rat. Childs Nerv Syst 23, 1171-1179. (Pubitemid 47399550)
21. Redell JB, Zhao J, Dash PK (2011) Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J Neurosci Res 89, 212-221.
22. Reeves TM, Lyeth BG, Povlishock JT (1995) Long-term potentiation deficits and excitability changes following traumatic brain injury. Exp Brain Res 106, 248-256.
23. Witgen BM, Lifshitz J, Smith ML, Schwarzbach E, Liang SL, Grady MS, CohenAS(2005) Regional hippocampal alteration associated with cognitive deficit following experimental brain injury:Asystems, network and cellular evaluation. Neuroscience 133, 1-15. (Pubitemid 40694154)
24. Cohen AS, Pfister BJ, Schwarzbach E, Grady MS, Goforth PB, Satin LS (2007) Injury-induced alterations in CNS electrophysiology. Prog Brain Res 161, 143-169. (Pubitemid 47023092)
25. Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 89, 121-145.
26. Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA, Cairns MJ (2011) Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry, doi: 10.1038/mp.2011.78.
27. Patanella AK, Zinno M, Quaranta D, Nociti V, Frisullo G, Gainotti G, Tonali PA, Batocchi AP,Marra C (2010) Correlations between peripheral blood mononuclear cell production ofBDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J Neurosci Res 88, 1106-1112.
28. van Heerden JH, Conesa A, Stein DJ, Montaner D, Russell V, Illing N (2009) Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse. BMC Res Note 2, 195.
29. Kim SM, Song J, Kim S, Han C, Park MH,KohY, Jo SA, Kim YY (2011) Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol 11, 51.
30. LeeST, Chu K, Jung KH, Park HK,KimDH, Bahn JJ,Kim JH, Oh MJ, Lee SK, Kim M, Roh JK (2009) Reduced circulating angiogenic cells in Alzheimer disease. Neurology 72, 1858-1863.
31. Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC (2011) Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimers Dement 7, 15-34.
32. Cederberg D, Siesjo P (2010) What has inflammation to do with traumatic brain injury? Childs Nerv Syst 26, 221-226.
33. Morganti-KossmannMC,Satgunaseelan L, Bye N,Kossmann T (2007) Modulation of immune response by head injury. Injury 38, 1392-1400. (Pubitemid 350192405)
34. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, Sharp DJ (2011) Inflammation after trauma: Microglial activation and traumatic brain injury. Ann Neurol 70, 374-383.
35. Tanriverdi F, Unluhizarci K, Kelestrimur F (2010) Persistent neuroinflammation may be involved in the pathogenesis of traumatic brain injury (TBI)-induced hypopituitarism: Potential genetic and autoimmune factors. J Neurotrauma 27, 301-302.
36. Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7, 22-30.
37. Cantor JB, Gordon WA, Schwartz ME, Charatz HJ, Ashman TA, Abramowitz S (2004) Child and parent responses to a brain injury screening questionnaire. Arch Phys Med Rehabil 85, S54-S60. (Pubitemid 38857935)
38. GordonWA, Haddad L, Brown M, Hibbard MR, SliwinskiM (2000) The sensitivity and specificity of self-reported symptoms in individuals with traumatic brain injury. Brain Inj 14, 21-33. (Pubitemid 30040153)
39. Kay T, Harrington DE, Adams R (1993) Definition of mild traumatic brain injury. J Head Trauma Rehabilit 8, 86-87. (Pubitemid 23270997)
40. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414. (Pubitemid 23346995)
41. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13, 1359-1362. (Pubitemid 350073592)
42. Huang RP (2004) Cytokine protein arrays. Methods Mol Biol 264, 215-231.
43. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487-1505.
44. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44, 83-98.
45. Haroutunian V, Perl DP, Purohit DP,Marin D, Khan K, Lantz M, Davis KL, Mohs RC (1998) Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 55, 1185-1191. (Pubitemid 28427489)
46. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
47. Rhodes JK, Sharkey J, Andrews PJ (2009) The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma 26, 507-525.
48. Stefini R, Catenacci E, Piva S, Sozzani S, Valerio A, Bergomi R, Cenzato M, Mortini P, Latronico N (2008) Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. J Neurosurg 108, 958-962. (Pubitemid 351656844)
49. Grammas P,OvaseR(2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 22, 837-842. (Pubitemid 34066550)
50. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T (1997) Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51, 135-138. (Pubitemid 27262094)
51. Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ (2005) Early correlation of microglial activation with enhanced tumor necrosis factoralpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2, 23.
52. Archer T, Svensson K, Alricsson M (2012) Physical exercise ameliorates deficits induced by traumatic brain injury. Acta Neurol Scand 125, 293-302.
53. Dams-O'Connor K, Gordon WA (2010) Role and impact of cognitive rehabilitation. Psychiatr Clin North Am 33, 893-904.
54. Qu C, Mahmood A, Ning R, Xiong Y, Zhang L, Chen J, Jiang H, Chopp M (2010) The treatment of traumatic brain injury with velcade. J Neurotrauma 27, 1625-1634.
55. Svetlov SI, Larner SF, Kirk DR, Atkinson J, Hayes RL,Wang KK (2009) Biomarkers of blast-induced neurotrauma: Profiling molecular and cellular mechanisms of blast brain injury. J Neurotrauma 26, 913-921.
56. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224, 93-100.
57. Correa JD, Starling D, Teixeira AL, Caramelli P, Silva TA (2011) Chemokines in CSF of Alzheimer's disease patients. Arq Neuropsiquiatr 69, 455-459.
58. Hickman SE, El KJ (2010) Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. CNS Neurol Disord Drug Targets 9, 168-173.
59. Kim JS (1996) Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 137, 69-78. (Pubitemid 26172036)
60. Kooij G, Mizee MR, van HJ, Reijerkerk A, Witte ME, Drexhage JA, van der Pol SM, van Het HB, Scheffer G, Scheper R, Dijkstra CD, van der Valk P, de vries HE (2011) Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: Relevance to multiple sclerosis pathogenesis. Brain 134, 555-570.
61. Mahad DJ, Ransohoff RM (2003) The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 15, 23-32. (Pubitemid 36092176)
62. Minami M, Satoh M (2003) Chemokines and their receptors in the brain: Pathophysiological roles in ischemic brain injury. Life Sci 74, 321-327. (Pubitemid 37357063)
63. Xia MQ, Hyman BT (1999) Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 5, 32-41. (Pubitemid 29051876)
64. Banisor I, Leist TP, Kalman B (2005) Involvement of beta-chemokines in the development of inflammatory demyelination. J Neuroinflammation 2, 7.
65. Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201, 223-226. (Pubitemid 26009985)
66. Cross AK,Woodroofe MN (1999) Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28, 183-189.
67. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112, 195-204.
68. Tang CY, Eaves EL, Dams-O'Connor K, Ho L, Leung E, Wong E, Carpenter D, Ng J, GordonWA, PasinettiGM(2012) Diffused disconnectivity in mild traumatic brain injury: A resting state fMRI and DTI study. Translational Neuroscience 3(1), 9-14.
69. Maller JJ, Thomson RH, Lewis PM, Rose SE, Pannek K, Fitzgerald PB (2010) Traumatic brain injury, major depression, and diffusion tensor imaging: Making connections. Brain Res Rev 64, 213-240.
70. Tasker RC, Westland AG, White DK, Williams GB (2010) Corpus callosum and inferior forebrain white matter microstructure are related to functional outcome from raised intracranial pressure in child traumatic brain injury. Dev Neurosci 32, 374-384.
71. Wilde EA, Chu Z, Bigler ED, Hunter JV, Fearing MA, Hanten G, Newsome MR, Scheibel RS, Li X, Levin HS (2006) Diffusion tensor imaging in the corpus callosum in children after moderate to severe traumatic brain injury. J Neurotrauma 23, 1412-1426. (Pubitemid 46489602)
72. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A (2000) In vivo fiber tractography using DT-MRI data. Magn Reson Med 44, 625-632.